About: Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $11.60 (+2.38%)
PLRZNASDAQPolyrizon Ltd. Ordinary Shares
Loading watchlist status…
Polyrizon Ltd. Ordinary Shares share price
PLRZ price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
PLRZ price performance
13.73%
5D
-20.82%
1M
36.63%
YTD
87.7%
1Y
PLRZ price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NASDAQ rank
N/ASector Rank
N/APLRZ details
PLRZ Market Signals